Amsurg (AMSG) Tops Q2 EPS by 13c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
AmSurg Reports Second-Quarter Adjusted Diluted EPS of $0.97 and Diluted EPS of $0.65
August 4, 2015 4:00 PM EDTIncreases 2015 Financial Guidance
Announces Acquisition of Bay Area Anesthesia, LLC in Tampa
NASHVILLE, Tenn.--(BUSINESS WIRE)-- AmSurg Corp. (NASDAQ: AMSG) today announced financial results for the second quarter ended June 30, 2015. The Companys results for the quarter included:
Net revenues of $642.0 million, an increase of 131% from the second quarter of 2014; Net earnings from continuing operations attributable to AmSurg common shareholders of $31.4 million. Adjusted net earnings of $49.9 million increased 131% from the second quarter of 2014;... More